颅面骨折血管内栓塞止血后迟发性创伤性脑出血概率更高
该回顾性研究纳入2015年1月1日至2022年12月31日本机构颅面骨折患者2519例,其中21例(0.8%)因颌面部大出血行血管内栓塞止血。多因素logistic回归显示,血管内栓塞是迟发或进展性颅内出血的独立因素(OR=5.71,p=0.028)。1:2倾向性评分匹配后,栓塞组迟发或进展性颅内出血发生率28.6% vs 7.1%(p=0.023),住院时间长(17.0 vs 15.0天,p=0.009),ICU停留时间长(10.0 vs 4.0天,p=0.004)。作者认为,接受血管内栓塞止血的颅面骨折患者迟发或进展性颅内出血概率更高。
要点
- 多因素logistic回归显示,血管内栓塞是颅面骨折患者迟发或进展性颅内出血的独立因素(OR=5.71,p=0.028)。
- 1:2倾向性评分匹配后,栓塞组迟发或进展性颅内出血发生率28.6% vs 未栓塞组7.1%(p=0.023)。
- 匹配后栓塞组住院时间17.0天 vs 未栓塞组15.0天(p=0.009)。
- 匹配后栓塞组ICU停留时间10.0天 vs 未栓塞组4.0天(p=0.004)。
- 研究期间2519例颅面骨折患者中仅21例(0.8%)因颌面部大出血接受血管内栓塞。
适用人群与场景
- 2015年1月1日至2022年12月31日期间就诊于本机构的颅面骨折患者,共2519例。
- 其中21例(0.8%)因颌面部大出血接受血管内栓塞止血。
红旗征与不能漏的情况
- 颅面骨折患者因颌面部大出血接受血管内栓塞止血后,可能发生迟发或进展性颅内出血;研究观察窗口为72小时内。
研究设计与关键结果
- 研究类型:回顾性研究;样本量2519例颅面骨折患者,其中21例(0.8%)接受血管内栓塞;单中心(本机构)。
- 多因素logistic回归:血管内栓塞是迟发或进展性颅内出血的独立因素(OR=5.71,p=0.028)。
- 1:2倾向性评分匹配后,栓塞组迟发或进展性颅内出血发生率28.6% vs 未栓塞组7.1%(p=0.023)。
- 1:2倾向性评分匹配后,栓塞组住院时间17.0天 vs 未栓塞组15.0天(p=0.009)。
- 1:2倾向性评分匹配后,栓塞组ICU停留时间10.0天 vs 未栓塞组4.0天(p=0.004)。
- 结局指标包括72小时内发生的迟发或进展性颅内出血、需要额外神经外科干预以及ICU和住院时间。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,接受血管内栓塞止血的颅面骨折患者迟发或进展性颅内出血概率更高,提示临床需关注此类患者栓塞后迟发或进展性颅内出血的发生。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: While angioembolization is occasionally required for craniofacial fracture patients who experience massive maxillofacial hemorrhage, complications such as headache, temporal-facial pain, soft tissue necrosis, and embolic material migration leading to stroke or blindness can arise. Few studies have explored delayed or progressive intracerebral hemorrhage (ICH) following angioembolization for craniofacial fractures.
METHODS: A retrospective review of craniofacial fracture patients from January 1, 2015, to December 31, 2022 at our institution was conducted. We applied univariate and multivariable logistic regression (MLR) analyses to assess whether angioembolization served as an independent factor for delayed or progressive ICH. Propensity score matching (PSM) was used to balance the groups of patients who underwent angioembolization with those who did not. Outcome measurements included delayed or progressive ICH occurring within 72 hours, the need for additional neurosurgical interventions, and the length of stay (LOS) in the intensive care unit (ICU) and hospital.
RESULTS: Of the 2,519 craniofacial fracture patients studied over an 8-year period, 21 (0.8%) underwent angioembolization for maxillofacial hemorrhage. MLR analysis revealed that angioembolization was an independent factor for delayed or progressive ICH (odds ratio=5.71, p = 0.028). After 1:2 PSM, patients who underwent angioembolization had greater rates of delayed or progressive ICH (28.6% vs. 7.1%, p = 0.023), an extended hospital LOS (17.0 vs. 15.0 days, p = 0.009) and a longer ICU LOS (10.0 vs. 4.0 days, p = 0.004).
CONCLUSIONS: A greater probability of delayed or progressive ICH was observed in craniofacial fracture patients who underwent angioembolization for maxillofacial hemostasis.
参考来源
- Li CY, Kang SC, Chen CC, et al. Angioembolization for hemostasis in craniofacial fractures had a higher probability of delayed traumatic intracerebral hemorrhage. Am J Emerg Med. 2024. PMID: 39514928. doi:10.1016/j.ajem.2024.10.047
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。